you could have made a motza, page-3

Just called the company this morning and got a call back from the Company Secretary within 15minutes. The discussions seem well under way regarding potential sale of biolab but I think they were forced into making the ASX release due to the story being leaked. Their preference may have been to hold off for a bit. They are going through the process sifting through all the expressions of interest but nothing has been put to the board yet. I think it will only be a matter of time as they seem keen to do the right thing for the shareholders and I did take that theres been a fair amount of interest in biolab.

Regarding the HSBC $50m seems a nonevent as they did not really need that facility so there is no need to replace it. They did indicate it costed something to keep it in place so I imagine some of the decision was with ALS and not just HSBC cutting it off. The CBA refinancing is coming up but I didn't go into detail and they will update the market as soon as their is anything to update.

Came away feeling quite good and still of the opinion ALS is riduculously underpriced.